Role of methyle blue in the management of mild, moderate and severe COVID-19 disease

Himmatrao Saluba Bawaskar, Pramodini Himmatrao Bawaskar

Open source

DOI
10.4103/jfmpc.jfmpc_2071_21
Published
2022-02
Container
Journal of Family Medicine and Primary Care
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.4103/jfmpc.jfmpc_2071_21,
  title = {Role of methyle blue in the management of mild, moderate and severe COVID-19 disease},
  author = {Himmatrao Saluba Bawaskar and Pramodini Himmatrao Bawaskar},
  year = {2022},
  journal = {Journal of Family Medicine and Primary Care},
  doi = {10.4103/jfmpc.jfmpc_2071_21},
  url = {https://doi.org/10.4103/jfmpc.jfmpc_2071_21}
}

RIS

TY  - JOUR
TI  - Role of methyle blue in the management of mild, moderate and severe COVID-19 disease
AU  - Himmatrao Saluba Bawaskar
AU  - Pramodini Himmatrao Bawaskar
PY  - 2022
JO  - Journal of Family Medicine and Primary Care
DO  - 10.4103/jfmpc.jfmpc_2071_21
UR  - https://doi.org/10.4103/jfmpc.jfmpc_2071_21
ER  - 

APA

Bawaskar, H. S., & Bawaskar, P. H. (2022). Role of methyle blue in the management of mild, moderate and severe COVID-19 disease. Journal of Family Medicine and Primary Care. https://doi.org/10.4103/jfmpc.jfmpc_2071_21

Source records